Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Iron pills boost blood donations in ghana trial

NCT ID NCT06101238

Disease control Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving low-dose iron supplements (65 mg daily) for 6 months helps people with low hemoglobin pass the blood donation screening and successfully donate within a year. Over 500 adults in Ghana who were deferred from donating due to low hemoglobin took part. Half received iron plus nutrition advice; the other half got nutrition advice only. Researchers tracked successful donations and side effects for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-dose elemental iron (65 mg daily)
What this could lead to
If successful, this could help blood banks increase safe donations by quickly restoring hemoglobin levels in deferred donors.
What could go wrong
This is a completed pragmatic trial in Ghana; results may not apply to other settings. Iron supplements can cause mild stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

533 people

The number who actually took part.

Started

Jan 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * individuals between 18 - 60 years who weigh at least 50kg * pass pre-donation screening using the NBSG standardized donor screening questionnaire * vital signs meet the NBSG requirement for blood donation * non-contact forehead temperature not exceeding 37.5°C * meeting acceptable requirements for skin lesions, needle marks and physical appearance. * willingness and ability to consent * understands one of English, Twi, Ewe, or Ga * deferred for low haemoglobin * intend to remain in the study during the entire length of the study Exclusion Criteria: * persons who have used iron supplementation within the past one month * potential donors who are found to have haemoglobin Hb \< 10g/dl (females) and Hb\<11g/dl (males) at screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood donation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood donation

Contacts and locations

Locations

  • University of Minnesota

    Minneapolis, Minnesota, 55414, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.